Non melanoma skin cancer, Skin cancer
Results
Phase 2
This trial looked at sonidegib (LDE225) for basal cell skin cancer that had spread. Basal cell cancer is the most common type of skin cancer. It is also called basal cell carcinoma or BCC.
Recruitment start: 30 August 2011
Recruitment end: 11 January 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr John Lear
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 05 Oct 2020
CRUK internal database number: 8395